Skip to main content
Clinical Trials/NCT06825585
NCT06825585CompletedNot Applicable

Efficacy and Visual Quality of Orthokeratology Lenses With Different Designs

Xiaoyan Yang1 site in 1 country60 target enrollmentStarted: January 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Changes in axial length

Study Overview

Brief Summary

Orthokeratology (ortho-k) lens is very effective in slowing down axial elongation in myopic children by 30% to 63% when compared to children wearing single-vision spectacles or contact lenses. More recently, it is reported that the children wearing orthok lens of smaller back optical zone diameter (BOZD) demonstrated a smaller axial elongation when compared to children wearing lens with larger BOZD. We aimed to explored the myopia efficacy and visual quality of ortho-k with different BOZD (5.0mm or 6.2mm).

Detailed Description

This prospective study aimed to evaluate the efficacy of orthokeratology lenses with different back optical zone diameters (BOZD) in slowing axial elongation. Additionally, visual quality will be assessed through measurements of wavefront aberrations, contrast sensitivity, and subjective visual quality using a validated questionnaire. The study seeks to explore the effectiveness of various Ortho-K lens designs and the potential factors influencing their outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
8 Years to 13 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age between 8 and 13 years.
  • •Subjective refraction under cycloplegia: spherical power between -4.00 D and
  • •1.00 D, with cylindrical power≤ 1.50 D.
  • •Best-corrected visual acuity (BCVA) of ≥ 1.0 based on subjective refraction.
  • •Willing to participate in the clinical trial and provide signed informed consent.

Exclusion Criteria

  • •One eye met the inclusion criteria
  • •Patients with systemic diseases causing immunocompromised or affecting orthokeratology
  • •There are other eye diseases that affect orthokeratology lens wearing, such as dacryocystitis, blepharitis, various inflammation, glaucoma, etc
  • •Abnormal cornea
  • •Previous corneal surgery or corneal trauma history
  • •Active keratitis (e.g., corneal infection)
  • •Patients with best corrected distance visual acuity of less than 5.0
  • •Patients with corneal flat curvature lower than 39.00D, or higher than 48.00D
  • •Patients with refractive instability
  • •Patients with overt strabismus
  • •The corneal epithelium showed obvious fluorescent staining, which was not suitable for patients wearing orthokeratology lenses
  • •Patients with dry eye are not suitable for orthokeratology
  • •Patients with corneal endothelial cell density less than 2000 cells /mm2
  • •Patients who had worn rigid contact lenses (including orthokeratology lenses) within the previous 30 days

Arms & Interventions

Experimental Group

Experimental

Myopic children who need OK lens treatment

Intervention: Orthokeratology with 5.0mm back optical zone diameter (Device)

Control group

Active Comparator

Myopic children who need OK lens treatment

Intervention: Orthokeratology with a 6.2 mm back optical zone diameter (Device)

Outcomes

Primary Outcomes

Changes in axial length

Time Frame: The change of baseline and 1years

Axial length was measured with a biometer

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Xiaoyan Yang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Xiaoyan Yang

Tianjin Eye Hospital

Tianjin Eye Hospital

Study Sites (1)

Loading locations...

Similar Trials